2024 Regular Session • Florida Legislature
H0491: Access to Appropriate Medications for Serious Mental Illness
Legislative Summary
Requires AHCA to approve drug products for Medicaid recipients for treatment of serious mental illness without step-therapy prior authorization; directs agency to include rate impact of this act in certain program rates that become effective on specified date.
Demographic Impact
Overall analysis of equity impact
90% Positive
High ConfidenceView detailed demographic breakdown ↓Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
11/16/2023
Filed
House of Representatives
11/30/2023
Referred to Select Committee on Health Innovation
House of Representatives
11/30/2023
Referred to Health Care Appropriations Subcommittee
House of Representatives
11/30/2023
Referred to Health & Human Services Committee
House of Representatives
11/30/2023
Now in Select Committee on Health Innovation
House of Representatives
1/9/2024
1st Reading (Original Filed Version)
House of Representatives
3/8/2024
Died in Select Committee on Health Innovation
House of Representatives
Status Information
Current Status
Failed(3/8/2024)
Chamber
House of Representatives
Sine DiePrior Session
Sponsors
Republican: 1
Primary Sponsor
Karen Gonzalez Pittman
Republican